SCHEMBL8375142

SCHEMBL8375142

CCCNc1ccncc1O.CCN(CC)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 12/20 0.58
KDM6B O15054 7/20 0.58
ECE1 P42892 1/20 0.41
MUS81 Q96NY9 1/20 0.41
LATS1 O95835 1/20 0.37
HCAR3 P49019 1/20 0.37
P2RX4 Q99571 1/20 0.36
IDO1 P14902 1/20 0.36
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KDM4A O75164 1/20 0.35
KDM4D Q6B0I6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8376698 0.89 KDM4C (0.43) KDM4CKDM6BP2RX4KDM4EALDH1A1
SCHEMBL8375139 0.85 KDM4C (0.57) KDM4CKDM6BECE1MUS81LATS1
SCHEMBL8374734 0.84 KDM4C (0.58) KDM4CKDM6BLATS1HCAR3P2RX4
Hydrochloric Acid SCHEMBL8375849 0.84 KDM4C (0.55) KDM4CKDM6BECE1MUS81LATS1
SCHEMBL8376730 0.83 KDM4C (0.56) KDM4CKDM6BKDM4ELMNAHPGD
SCHEMBL8376711 0.82 HSD17B10 (0.42) KDM4CKDM6BP2RX4KDM4EALDH1A1
SCHEMBL8375851 0.76 KDM4C (0.59) KDM4CKDM6BLATS1HCAR3ALDH1A1
SCHEMBL8375133 0.76 CYP17A1 (0.41) KDM4CKDM6BIDO1KDM4E
SCHEMBL8375140 0.76 KDM6B (0.51) KDM4CKDM6BECE1MUS81LATS1
SCHEMBL8375145 0.76 LMNA (0.44) KDM4CKDM6BP2RX4KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US claimed
US-5869480-A ALLEVIATING MEMORY DYSFUNCTION CHARACTERIZED BY CHOLINERGIC DEFICIT HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5866565-A ALZHEIMER'S DISORDERS HOECHST MARION ROUSSEL INC. (US) 1999-02-02 US disclosed
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US disclosed
EP-0477903-A2 Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-04-01 EP disclosed